Mortality in congenital hemophilia A – a systematic literature review

por Hay, Charles R. M., Nissen, Francis, Pipe, Steven W.
Publicado 2020

Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A:...

por Oldenburg, Johannes, Hay, Charles R M, Jiménez-Yuste, Víctor, Peyvandi, Flora, Schved, Jean-François, Szamosi, Johan, Winding, Bent, Lethagen, Stefan
Publicado 2019

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database

por Peyvandi, Flora, Mahlangu, Johnny N., Pipe, Steven W., Hay, Charles R. M., Pierce, Glenn F., Kuebler, Peter, Kruse‐Jarres, Rebecca, Shima, Midori
Publicado 2020

Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company

por Hay, Charles R. M., Shima, Midori, Makris, Michael, Jiménez‐Yuste, Victor, Oldenburg, Johannes, Fischer, Kathelijn, Iorio, Alfonso, Skinner, Mark W., Santagostino, Elena, von Mackensen, Sylvia, Kessler, Craig M.
Publicado 2020

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database

por Pipe, Steven W., Kruse‐Jarres, Rebecca, Mahlangu, Johnny N., Pierce, Glenn F., Peyvandi, Flora, Kuebler, Peter, De Ford, Christian, Sanabria, Fabián, Ko, Richard H., Chang, Tiffany, Hay, Charles R. M.
Publicado 2020